For the Media
Dr.Marie Bleakley is an associate member of Fred Hutch's Clinical Research Division and a member of the Program in Immunology. She is a pediatric oncologist with expertise in hematopoietic (blood-forming) stem cell transplantation (HCT) to treat leukemia. Her research is focused on improving outcomes for patients with high-risk leukemia by developing new strategies that optimize the activities of T cells in the context of hemapoietic transplantation.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.